MedTrace Logo

A Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Arabia

NCT06714448 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 455

Last updated 2026-04-28

No results posted yet for this study

Summary

A cross-sectional, national, multicenter, survey-based study to assess the effectiveness of Risk Minimization Measures related to Depakine® (sodium valproate) in Saudi Arabia. The end of study is defined as the end of the data collection period. No intervention will be administered, and no study related visits are required.

Conditions

Interventions

DRUG

Sodium valporate

This study will not administer any treatment, only observe the treatment as prescribed in real-world clinical practices.

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-29
Primary Completion
2025-09-22
Completion
2025-09-22

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06714448 on ClinicalTrials.gov